$ZYNE News Article - Zynerba Pharmaceuticals Presents Longer Term Tolerability and Efficacy Data of Zygel(TM) in Children and Adolescents with Autism Spectrum Disorder (ASD) at The Society for the Study of Behavioural Phenotypes (SSBP) Conference 2021
https://marketwirenews.com/news-releases/zyne...31494.html